Hyperlipidemias Flashcards
Name the 6 groups used in the treatment of hyperlipidemias
- Statins
- Fibrates
- Resins/ Bile Acid Sequestrians
- Cholesterol absorption inhibitors/ Ezetimibe
- Niacin
- PCSK9 Inhibitors
Statins Examples
ATORVASTATIN FLUVASTATIN ROSUVASTATIN SIMVASTATIN
Stains MOA
Blocks enzyme HMG-COA reductase
Decreases intracellular total cholesterol because mevelonate needs this to become cholesterol. Decreases cholesterol makes the liver increase LDL receptors to increase cholesterol therefore bringing in LDL from blood.
(HMG-COA won’t be converted to Mavulonic acid (precursor of cholesterol) → Upregulates LDL-r
Statins S/Es
Liver Toxicity Increased liver enzymes/ aminotransferases Headache Nausea Skin Rashes Hepatotoxicity GI disturbances
Myopathy Rhabdo ( Rhabdo occurs when damaged muscle tissue releases its proteins and electrolytes into the blood.)
Contraindications of Statins
Unexplained elevated levels of aminotransferase
Pregnancy/ Teens/ Kids
Active hepatic disease
History of liver disease
Niacin MOA
Strongly inhibits lipolysis in adipose tissue, thereby reducing production of free fatty acids
Reduced liver triglyceride levels decrease hepatic VLDL production, which in turn
reduces LDL-C plasma concentrations
Decreases catabolism of apoA-1
Reduces VLDL secretion from liver
Increased HDL cholesterol
Niacin USES
● Familial hyperlipidemias
● severe hypercholesterolemia
● Low HDL cholesterol
● Elevated VLDL and LDL
Niacin Side/Effects
Intense cutaneous flushing
Hyperurcemia and Goat
Incr. risk of hyperuricemia
Niacin CONTRAINDICATIONS
Diabetes,
kidney and liver disease
hypertension
Fibrate examples
Gemfibrozil
Fenofibrate
Fibrate MOA
● PPAR-ɑ(alpha) agonist
● Peroxisome proliferator–activated receptors (PPARs) are members of the nuclear
receptor family that regulate lipid metabolism.
● PPARs function as ligand-activated transcription factors
● Upon binding to their natural ligands (fatty acids or eicosanoids) or antihyperlipidemic
drugs, PPARs are activated.
● They then bind to peroxisome proliferator response elements, which ultimately leads to
decreased triglyceride concentrations through increased expression of lipoprotein lipase (Figure 22.9) and decreased apolipoprotein (apo) CII concentration
Similarly it binds to ppr-a found in adipose tissue and when bound it inactive dates certain genes involved in fat metabolism
Fibrates USES
● Hypertriglyceridemias
● type III hyperlipidemia (dys-beta-lipo-protein-emia
decreases triglycerides
Fibrates ADVERSE EFFECTS
● mild gastrointestinal (GI) disturbances
● Formation of cholesterol gallstones- d/t increased biliary excretion
● Myositis
● Myopathy - for patients taking gemfibrozil and statins together
● Rhabdomyolysis - for patients taking gemfibrozil and statins together
● Both fibrates may increase the effects of warfarin
Leukopenia
Decreased hematocrits
Pancreatitis
Fibrates CONTRAINDICATIONS
● renal insufficiency
● gemfibrozil is contraindicated with simvastatin
● gemfibrozil with any statin should be avoided
● severe hepatic or renal dysfunction
● patients with preexisting gallbladder disease
● biliary cirrhosis
Pregnancy
Hepatorenal dysfunction
Gallbladder
Bile acid sequestrants/ Resins EXAMPLE
CHOLESTIPOL CHOLESTYRAMINE CHOLESEVALAM
Bile acid sequestrates/ Resins MOA
Bind to bile acids preventing their reabsorption back into blood because they function as anion exchange resins –> An insoluble resin/bile acid complex–> leading to no reabsorption because bile acids are made from cholesterol so hepatocytes increase ldl receptors to replace the lost cholesterol by bringing in more cholesterol leading to a decreased blood LDL
● anion-exchange resins that bind negatively charged bile acids and bile salts in the small intestine
● The resin/bile acid complex is excreted in the feces, thus lowering the bile acid concentration
● This causes hepatocytes to increase conversion of cholesterol to bile acids, which are essential components of the bile.
● intracellular cholesterol concentrations decrease, which activates an increased hepatic uptake of cholesterol-containing LDL-C particles, leading to a decrease in plasma LDL-
Bile acid sequestrates/ Resins USES
● type IIA hyperlipidemias
● type IIB hyperlipidemias
● Pruritus
● type 2 diabetes